


The publications included in this reference list reflect a sampling of studies and articles on ADHD published in reputable medical journals. This list of references was produced by third parties over whom Novartis Pharmaceuticals Corporation has no control. As such, Novartis Pharmaceuticals Corporation makes no representation as to the accuracy or any other aspect of the information contained in such resources. Web sites have been listed below for additional information about these publications.
American Academy of Pediatrics. Clinical Practice Guideline: Diagnosis and Evaluation of the Child With Attention-Deficit/Hyperactivity Disorder. Pediatrics. May 2000;105:1158-1170
www.pediatrics.org
Barkley, R., DePaul, G., & Connors, D. Stimulants. Practitioner's Guide to Psychoactive Drugs for Children and Adolescents. 1999: 213-214
Biederman, J., Wilens, T., Micke, E., Spencer, T., & Faraone, SV. Pharmacotherapy of Attention-Deficit/Hyperactivity Disorder Reduces Risk for Substance Use Disorder. Pediatrics. August 1999: 104(2)
www.pediatrics.org
Committee on Children with Disabilities and Committee on Drugs. Medication for Children With Attentional Disorders. Pediatrics. August 1996; 98(2): 301-304
www.pediatrics.org
Cyr, M., & Brown, CS. Current Drug Therapy Recommendations for the Treatment of Attention Deficit Hyperactivity Disorder. Drugs. August 1998; 56(2): 215-223 www.adis.com/page.asp?ObjectID=36
Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV). Attention-Deficit/Hyperactivity Disorder. American Psychiatric Association. Washington, D.C. 1994
Dulcan, M. Practice Parameters for the Assessment and Treatment of Children, Adolescents, and Adults with Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child and Adolescent Psychiatry. Supplement, October 1997; 36(10): 85S-121S www.jaacap.com
|